Patient profile impacts QOL with radiation Tx in head, neck cancer

August 11, 2017

(HealthDay)—There are patient characteristics and clinical factors independently associated with physical and mental quality of life (QOL) in patients with head and neck cancer undergoing radiotherapy, according to a study published online Aug. 2 in Head & Neck.

Guro Lindviksmoen Astrup, from Oslo University Hospital in Norway, and colleagues evaluated 133 patients with head and . From the initiation of radiotherapy through six months of follow-up, patients rated physical and mental QOL using the Short Form-12 five times.

The researchers found that QOL deteriorated during radiotherapy and gradually improved after completion. There was a negative association between less and both physical and mental QOL. There were also negative associations between older age, more comorbidities, more psychological symptoms, and concomitant chemotherapy with physical QOL. There were positive associations for male sex, fewer physical symptoms, surgery before , and concomitant chemotherapy with mental QOL.

"Clinicians can use knowledge on time course and associated characteristics to identify and inform patients at higher risk for diminished QOL," the authors write.

Explore further: More side effects with CRT plus metformin in head, neck cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

More side effects with CRT plus metformin in head, neck cancer

May 7, 2017
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...

Depression up in post-radiation head and neck cancer survivors

August 16, 2013
(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

Reduced cancer-independent life expectancy in head, neck cancer

June 27, 2017
(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

Empowerment linked to HRQoL in teen, young adult CA survivors

July 17, 2017
(HealthDay)—For adolescent and young adult (AYA) cancer survivors, empowerment is independently associated with health-related quality of life (HRQoL), according to research published online July 11 in Cancer.

Researchers urge radiotherapy for all patients with bone mets

February 13, 2017
(HealthDay)—For patients with bone metastases, those responding to radiotherapy experience greater pain reduction and better quality of life (QOL) at day 10 after radiotherapy, according to a study published online Feb. ...

High-observation protocol cuts length of stay in head, neck CA

July 7, 2017
(HealthDay)—A high-observation protocol (HOP) appears to optimize clinical care for patients with head and neck cancer undergoing primary surgery, according to a study published online June 20 in Head & Neck.

Recommended for you

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.